| mRNA |
navitoclax:sorafenib (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.074 |
0.04 |
| mRNA |
AZD8055 |
CTRPv2 |
pan-cancer |
AAC |
0.074 |
0.05 |
| mRNA |
Gemcitabine |
CTRPv2 |
pan-cancer |
AAC |
0.069 |
0.05 |
| mRNA |
Cetuximab |
GDSC1000 |
pan-cancer |
AAC |
-0.066 |
0.05 |
| mRNA |
methylstat |
CTRPv2 |
pan-cancer |
AAC |
0.086 |
0.05 |
| mRNA |
linifanib |
CTRPv2 |
pan-cancer |
AAC |
0.073 |
0.05 |
| mRNA |
semagacestat |
CTRPv2 |
pan-cancer |
AAC |
-0.076 |
0.05 |
| mRNA |
lapatinib |
GDSC1000 |
pan-cancer |
AAC |
-0.097 |
0.05 |
| mRNA |
compound 1B |
CTRPv2 |
pan-cancer |
AAC |
-0.079 |
0.05 |
| mRNA |
BRD9876:MK-1775 (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.25 |
0.05 |